Tomorrow Conference call at 12est not good

[anonymous]

Good bye all I was affected today will always remember launch in Vegas, Alan b and dove child mary holding hands with those succulent Asian pies

 

[anonymous]

Seems like necessary decisions were made this week. Not pleasant, but necessary. Needed to get out of areas where we had no coverage. Now we better grow where we do have coverage or else!

 

[anonymous]

Seems like necessary decisions were made this week. Not pleasant, but necessary. Needed to get out of areas where we had no coverage. Now we better grow where we do have coverage or else!

We need to grow Zorvolex and Tivorbex ASAP or we will be gone soon.

 

[anonymous]

I'm trying selbash but only 2 Tiv scripts so far these docs hate it and so do I, take it away Neil!

 

[anonymous]

i heard 8 RBM's

 

[anonymous]

Remember, we're a contract. If we're not profitable, we're done. That simple. Guess what? We're not profitable. And with these drugs, guess what? We're done!!!

 

[anonymous]

We need to grow Zorvolex and Tivorbex ASAP or we will be gone soon.

Lots of good people lost their jobs because it was impossible to sell these drugs. Ultimately, Iroko has not laid the groundwork for success. Sales are declining because the drs are frustrated by the process. Even if the good areas stay afloat, Iroko will need to reconquer the areas they have abandoned to be successful. You can't reattach an arm you amputated. Our managed care team has failed this company.

 

[anonymous]

these are good products and absolutely can be sold where we have good coverage. It made sense to get out of areas where we didn't have good coverage. No thanks to the old regime for putting us there. Not set up for success at launch. But we are now.

 

[anonymous]

Glad I got out. Iroko hasn't been profitable since day 1 and I think its a sinking ship.

 

[anonymous]

these are good products and absolutely can be sold where we have good coverage. It made sense to get out of areas where we didn't have good coverage. No thanks to the old regime for putting us there. Not set up for success at launch. But we are now.

Keeping reps in TX, AL, NJ and OK is the new recipe for success in big pharma. When was the last time a rep from another state was on the leaderboard?
Iroko has solid coverage in 18% of the US!!! Suck it Horizon....